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Escherichia coli lipoprotein binds
human plasminogen via an
intramolecular domain
Tammy Gonzalez†‡, Robert A. Gaultney‡, Angela M. Floden and Catherine A. Brissette*
Brissette Laboratory, Department of Basic Sciences, University of North Dakota School of Medicine and Health Sciences,
Grand Forks, ND, USA
Escherichia coli lipoprotein (Lpp) is a major cellular component that exists in two
distinct states, bound-form and free-form. Bound-form Lpp is known to interact with
the periplasmic bacterial cell wall, while free-form Lpp is localized to the bacterial cell
surface. A function for surface-exposed Lpp has yet to be determined. We hypothesized
that the presence of C-terminal lysinses in the surface-exposed region of Lpp would
facilitate binding to the host zymogen plasminogen (Plg), a protease commandeered by
a number of clinically important bacteria. Recombinant Lpp was synthesized and the
binding of Lpp to Plg, the effect of various inhibitors on this binding, and the effects of
various mutations of Lpp on Lpp–Plg interactions were examined. Additionally, the ability
of Lpp-bound Plg to be converted to active plasmin was analyzed. We determined that
Lpp binds Plg via an atypical domain located near the center of mature Lpp that may
not be exposed on the surface of intact E. coli according to the current localization
model. Finally, we found that Plg bound by Lpp can be converted to active plasmin.
While the consequences of Lpp binding Plg are unclear, these results prompt further
investigation of the ability of surface exposed Lpp to interact with host molecules such
as extracellular matrix components and complement regulators, and the role of these
interactions in infections caused by E. coli and other bacteria.
Keywords: plasminogen, lipoprotein, E. coli, binding
Introduction
Murein lipoprotein (Lpp) —originally discovered in Escherichia coli—is the largest protein
substituent, by molarity, in many species of Gram-negative bacteria (Braun and Sieglin, 1970;
Braun and Wolﬀ, 1970; Neidhardt and Curtiss, 1996; Sha et al., 2004; van Lier et al., 2014). The
characterized function of Lpp is to anchor the outer membrane to the bacterial cell wall, aiding
in stability and durability of the bacterial cell as a whole. Functional, bound-form Lpp is attached
via its lipid moiety to the periplasmic leaﬂet of the outer membrane where the lipoprotein can
be covalently attached to peptidoglycan (PG; Bernstein, 2011). However, a second population of
Lpp exists in E. coli: that of a free-form (non-PG-bound) Lpp (Inouye et al., 1972). The subcellular
localization of free-form Lpp has recently been described (Cowles et al., 2011). Current data suggest
that free-form Lpp transverses the outer membrane such that the protein’s carboxyl terminus is
exposed while the amino terminus remains unavailable—either remaining in the periplasm or
becoming embedded within the outer membrane itself (Bernstein, 2011; Cowles et al., 2011).
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A function for this free-form Lpp has yet to be determined.
It has been posited that this population may serve as storage for
future use as bound-form Lpp, although this hypothesis remains
untested (Cowles et al., 2011). Our laboratory has an interest
in bacterial lipoproteins as many have been characterized
with important roles in adhesion and immune evasion
(El-Hage et al., 2001; Kovacs-Simon et al., 2011; Zückert,
2014). We noted a striking feature on the proposed model of
Lpp membrane insertion: the presence of C-terminal lysine
residues (Shu et al., 2000). C-terminal lysines on bacterial
lipoproteins have been shown to be important in the binding
of the speciﬁc host protease precursor plasminogen (Plg),
and many characterized Plg-binding proteins have this motif
(Miles et al., 1991; Fulde et al., 2013). Plg is a serine protease
present in serum as an inactive proenzyme. Plg is converted
by tissue-type plasminogen activator (tPA) or urokinase
plasminogen activator (uPA) to active plasmin (Fulde et al.,
2013). Plasmin’s normal function is to aid wound repair and
clot degradation; as it has a critical role in host ﬁbrinolysis
and extracellular matrix remodeling, plasmin’s activity is
tightly controlled. Binding of Plg by mammalian Plg receptors
is mediated by lysine-binding Kringle domains (Wiman
et al., 1979). Binding of Plg to a mammalian receptor, ﬁbrin
clot, or a bacterial cell facilitates its activation to plasmin
and makes the molecule less susceptible to inactivation
(Lähteenmäki et al., 2001). Although plasmin’s normal
function is to aid wound repair and clot degradation, many
bacterial pathogens are able to hijack the host Plg/plasmin
system and use its protease activity for dissemination from
the original site of infection or to evade host immune
response (Suomalainen et al., 2007; Bhattacharya et al.,
2012; Önder et al., 2012). Indeed, E. coli possesses Plg-binding
proteins (Parkkinen and Korhonen, 1989; Sjöbring et al.,
1994).
In this study, we sought to determine the potential for
Lpp to act as a Plg-binding protein, and the mechanisms
on which this interaction depends, originating with the
hypothesis that the C-terminal lysines facilitate this interaction.
In summary, we found that Lpp was able to bind this host
protein, albeit via an unexpected mechanism. In doing
so, we also raise questions regarding the hypothesized
orientation of free-form Lpp that we hope will contribute
to future discussions regarding this abundant and interesting
lipoprotein.
Materials and Methods
Alignment
The alignment of E. coli Lpp was performed via clustalW2
(Larkin et al., 2007) with the following accession sequence
numbers: E. coli- WP_000648420.1; Salmonella enterica-
AEF07247.1; Shigella flexneri- ABF03869.1; Klebsiella
pneumoniae- EYB76101.1. For the rLPP and PDHB peptide
alignment, sequences used were those presented in the paper.
All parameters used were program defaults. Residues are
annotated as follows: : = conservation of strong groups,
• = conservation of weak groups, and ∗ = fully conserved
residue.
rLpp and Mutant Protein Production
Lipoprotein lacking the N-terminal 21 residues was cloned into
the pET200 expression vector (Life Technologies; Carlsbad, CA,
USA). Resultant colonies were screened by PCR, and correct
insertion into the vector plasmid was conﬁrmed via bi-directional
Sanger sequencing (Davis Sequencing). To produce proteins,
plasmids with the appropriate inserts were transformed into
the BL21-Star strain E. coli (Life Technologies), and single
colonies were transferred to an overnight culture of super
broth (SB). The following day, inoculated SB was diluted 1:100
in fresh SB, and cells were grown to an optical density of
approximately 0.5, after which time the cells were stimulated
with 0.3 mM IPTG for 3–4 h. Cells were spun down, re-
suspended in binding buﬀer (100 mMHEPES, 10 mM imidazole,
1 mg/mL lysozyme pH 7.5) for 1 h. Cells were subsequently
lysed with a sonic dismembrator Model 705 (Fisher Scientiﬁc;
Waltham, MA, USA) with the following protocol: 15 s at
amplitude 100, 30 s rest for a total of eight cycles in an ice-
water bath. Lysates were centrifuged and the soluble fraction
was transferred to a new tube with 1 volume Magne-His
beads (Promega; Madison, WI, USA) per 20 volumes of lysate.
Lysates were allowed to interact with the beads for at least
30 min, after which time the supernatants were removed
while beads were sequestered via magnetic stands and new
binding buﬀer was added for 30 min to wash cells. This step
was repeated twice for a total of three washes. To recover
proteins, elution buﬀer (1 M imidazole, 100 mM HEPES, pH
7.5) was added to the beads and also allowed to act for at
least 30 min. After removal of this buﬀer, this elution step
was repeated once. Proteins in the elution were dialyzed into
PBS with 3 kDa molecular weight cutoﬀ dialysis cassettes (Life
Technologies).
To produce mutants of Lpp, two techniques were employed,
both of which use the primers detailed in Table 1. For C-terminal
truncations and individual nucleotide substitutions, site-directed
mutagenesis (SDM; Agilent; Santa Clara, CA, USA) was used to
generate a premature stop codon in desired locations. Primers
for this protocol were designed at the manufacturer’s website1 ,
and the protocol followed was as described by the manufacturer.
Brieﬂy, parent plasmid was ampliﬁed with the SDM primers,
the reaction was treated with DpnI provided in the kit, and the
DNA was transformed into XL1 Blue E. coli, as recommended.
Bacteria were plated on LB agar supplemented with kanamycin,
and resultant colonies were moved into overnight culture.
Plasmids for the culture were puriﬁed and sent for bi-directional
Sanger sequencing as above to verify mutation of the desired
nucleotides.
To create N-terminal truncations, overlap deletion PCR
was performed using the Expand High-ﬁdelity PCR system
(Roche; Indianapolis, IN, USA). The DNA was ampliﬁed with
the following protocol: 94◦C-3 min; (94◦C-30 s, 50◦C-30 s,
1www.genomics.agilent.com/primerDesignProgram.jsp
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TABLE 1 | A list of primers generated in this study and their functions.
Primer name Sequence (5′–3′ ) Function/peptide generated (also, see Table 2)
lpp pET For CAC CTC CAG CAA CGC TAA AAT CG Clone recombinant lipoprotein (lpp) into pET200 expression
vector
lpp pET Rev TTA CTT GCG GTA TTT AGT AGC
lpp10CF GCT CGT GCT AAC CAG CGT TAG GAC AAC ATG GCT
ACT
Insert premature stop codon to remove 10 residues from Lpp
C-term
lpp10CR AGT AGC CAT GTT GTC CTA ACG CTG GTT AGC ACG
ACG
lpp30CF CTG AGC AAC GAC GTG TAG GAC ATG CGT TCC GAC Insert premature stop codon to remove 30 residues from Lpp
C-term
lpp30CR GTC GGA ACG CAT TGC CTA CAC GTC GTT GCT CAG
lpp10NF CCC TTC ACC TCT GAC GTT CAG ACT CTG AAC Overlap deletion PCR to delete N-term 10 residues from Lpp
lpp10NR AAC GTC AGA GGT GAA GGG ATG ATC CTT ATC
lpp20NF CCC TTC ACC GAC CAG CTG AGC AAC GAC GTG Overlap deletion PCR to delete N-term 20 residues from Lpp
lpp20NR CAG CTG GTC GGT GAA GGG ATG ATC CTT ATC
lpp30NF CCC TTC ACC CGT TCC GAC GTT CAG GCT GCT Overlap deletion PCR to delete N-term 30 residues from Lpp
lpp30NR GTC GGA ACG GGT GAA GGG ATG ATC CTT ATC
lppK19 A For GCT CAG CTG GTC AAC TGC AGC GTT CAG AGT CTG
AAC G
Mutate lysine at site 19 in rLpp to alanine
lppK19 A Rev CGT TCA GAC TCT GAA CGC TGC AGT TGA CCA GCT
GAG C
LppQ14A N17A For CGA TCA GCT GTC TTC TGA CGT TGC GAC TCT GGC
CGC TAA AGT TGA CCA G
Mutate both glutamine (site 14) and asparagine (site 17) to
alanines
LppQ14A N17A Rev CTG GTC AAC TTT AGC GGC CAG AGT CGC AAC GTC
AGA AGA CAG CTG ATC G
lppL16R A18R For CTT CTG ACG TTC AGA CTC GGA ACC GTA AAG TTG
ACC AGC TGA G
Mutate both leucine (site 16) and alanine (site 18) to arginines
lppL16R A18R Rev CTC AGC TGG TCA ACT TTA CGG TTC CGA GTC TGA
ACG TCA GAA G
lppA18K For GTT GCT CAG CTG GTC AAC TTT CTT GTT CAG AGT
CTG AAC GTC AGA
Mutate alanine at site 18 in rLpp to lysine
lppA18K Rev TCT GAC GTT CAG ACT CTG AAC AAG AAA GTT GAC
CAG CTG AGC AAC
LppL16K For CTG GTC AAC TTT AGC GTT CTT AGT CTG AAC GTC
AGA AGA C
Mutate leucine at site 16 in rLPP to lysine
LppL16K Rev GTC TTC TGA CGT TCA GAC TAA GAA CGC TAA AGT
TGA CCA G
67◦C-6 min) for 10 cycles; (94◦C-30 s, 50◦C-30 s, 67◦C-
6 min + 15 s/cycle) for 25 cycles; and a ﬁnal extension of 67◦C
for 7min. Subsequent steps were carried out similarly to the SDM
protocol.
Antibody Production
Antibodies were produced in house using Balb/C mice
(Harlan, Madison, WI, USA). To stimulate antibody production,
4–6 week-old animals were subcutaneously injected biweekly
with a 1:1 solution of His-tagged rLpp in PBS: alhydrogel
(Invivogen; San Diego, CA, USA). A total of four biweekly
booster injections were performed on each mouse. Serum
was collected before and after the experiment to analyze
diﬀerences in reactivity against rLpp. Mice were euthanized
via CO2 inhalation followed by cervical dislocation, and whole
blood was collected in heparin-coated tubes. To separate
the cellular and serum fractions, the sample was spun at
8000 times g for 10 min. Serum was saved for use in
immunochemical analyses and the cellular fraction of the
blood was discarded. The UND Institutional Animal Care
and Use Committee approved the protocol for immunization
(protocol #1406-2C). All eﬀorts were made to minimize animal
suﬀering.
Enzyme-linked Immunosorbent Assays
(ELISAs)
Enzyme-linked Immunosorbent Assays used to analyze binding
were performed as follows. Nuncmaxisorp 96-well plates (Fisher)
were treated overnight at 4◦C with 100 μL of 10 μg/mL Plg
or plasmin in ELISA coating buﬀer (0.32 g Na2CO3, 0.586 g
NaHCO3 per 200 mL, pH = 9.6). The wells were subsequently
washed three times with PBS supplemented with 0.05% Tween
(PBST), and the plates were blocked for at least 1 h with
300 μL of a 1% gelatin solution in PBS. The blocked plates
were washed again as above before the detailed amounts of the
rLpp and derived mutant proteins were added to the appropriate
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FIGURE 1 | The primary structure of lipoprotein (Lpp) in Enterobacteriaceae may allow for plasminogen (Plg) binding. An alignment of Escherichia coli
Lpp amino acid sequence with that of other Enterobacteriaceae using clustalW2. Accession numbers used are listed in the “Materials and Methods” section.
Residues are annotated as follows: : = conservation of strong groups, • = conservation of weak groups, and * = fully conserved residue.
FIGURE 2 | Lpp binds Plg. Enzyme-linked immunosorbent assays (ELISAs) were performed for experiments in which Lpp was allowed to interact with bound Plg
(A) or plasmin (B) and values are blanked against those of Lpp interactions with bound BSA. The inhibitors NaF (C) and 6-aminocaproic acid, (ACA) a lysine analog
(D) were used to determine the roles of ionic interactions and lysine residues, respectively. ∗p < 0.05 compared to untreated (no inhibitor) control.
wells and allowed to bind for 1 h at 37◦C. The plates were
washed again as above and treated with αLpp mouse serum—
generated as described above—at a dilution of 1:500 in PBS for
1 h at room temperature. Another wash was performed, and
a secondary αMouse IgG conjugated to horseradish peroxidase
(GE Healthcare; Pittsburgh, PA, USA) was added at a dilution of
1:5000 in PBS for another hour at room temperature. A ﬁnal wash
was performed prior to addition of Turbo TMB ELISA substrate
(Thermo). Upon development of a blue color, 2N H2SO4 was
added to the wells to stop activity and the plates were read
at a wavelength of 450 nm on a Biotek Epoch plate reader
(Winooski, VT, USA) to assess binding. All volumes used were
100 μL except for the blocking step. KD was determined as the
concentration of substrate at half of maximal binding (Floden
et al., 2011).
Western Blot
To assess antibody reactivity against our various Lpp mutants,
100 ng of each protein were run on a 12.5 or 20% SDS-PAGE
gel. After migration in a gel, the bands were transferred to a
nitrocellulose membrane that was subsequently blocked with
5% non-fat dried milk in TBS-Tween overnight at 4◦C. After
blocking, the membranes were washed three times in TBST.
Mouse serum diluted 1:1000 in TBST was used to probe each
protein for binding for 1 h at room temperature. This was
followed by another wash and the addition of a solution of
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1:12,000 diluted anti-mouse IgG-HRP. Proteins were detected
using SuperSignal West Pico Chemiluminescent Substrate (Life
Technologies). Images were captured with the Odyssey Fc
imaging system and accompanying software (LI-COR; Lincoln,
NE, USA).
Plasminogen Activation Assay
Ninety-six-well plates were coated with 100 μl of 10μg/ml BSA,
Lpp, and enolase as a positive control (Floden et al., 2011)
overnight at 4◦C. The plates were brought to room temperature
and washed once with PBST, then blocked with 300μL PBS+ 2%
BSA for 2 h at room temperature. After another three washes
with PBST, 2 μg of Plg were added to pertinent wells. The plate
was washed three times with PBST and human uPA activator at
a concentration of 4 ng/well was added. A substrate was made
by adding D-valyl-leucyl-lysine-p-nitroanilide dihydrochloride
(Sigma–Aldrich; St. Louis, MO, USA) at a concentration of
0.3 mM in a solution of 64 mM Tris HCl, 350 mM NaCl,
0.15% Triton X-100, pH 7.5. The substrate was then added and
incubated overnight at 37◦C. The spectrophotometer employed
for the ELISAs was used to detect the color change at 405 nm. All
volumes used besides the blocking step were 100 μL.
Whole Cell Binding Assay
A whole-cell binding assay was adapted from a previously
published protocol (Probert and Johnson, 1998). Brieﬂy, Plg
(10 μg/mL) was immobilized onto clean glass microscope slides
in PBS overnight at 4◦C. Slides were subsequently washed three
times in PBS for 5 min each, blocked with a solution of 3% BSA
in PBS for 2 h at room temperature, then washed again. E. coli
MG1655 (Guyer et al., 1981) was incubated with either αLpp
antibodies or mouse pre-immune serum (as a control) for 30 min
at room temperature, added to the slides at a concentration
of 5 × 106 bacteria per mL, and allowed to bind for 1.5 h at
37◦C. After binding, slides were washed extensively with PBS,
and bacteria were enumerated at 400× total magniﬁcation on
a BX53 microscope with a darkﬁeld ﬁlter (Olympus; Center
Valley, PA, USA). The average of 10 ﬁelds of view was used
to determine numbers, with multiple slides used per replicate.
Numbers reported are those averages, minus the number of
bacteria that were bound to untreated slides (BSA treated only).
Statistical Analysis
Statistical analysis was performed via one-way ANOVA with
a Tukey’s post hoc test, when applicable2. An asterisk on a
ﬁgure represents a p-value less than 0.05 when compared to
the appropriate control, as detailed in the ﬁgure legends. All
experiments were performed at least three times with similar
results between replicates. All error bars indicate SEM of the
replicates used.
Results
Lpp Binds Plg and Plasmin in a
Dose-dependent Manner
To begin our characterization of Lpp, we examined the primary
structure for motifs that would be common in a Plg-binding
protein. Many Plg receptors function via lysine-dependent
mechanisms (Wiman et al., 1979; Miles et al., 1991), which led
us to hypothesize that the C-terminal lysines of Lpp (Figure 1)
could allow for the binding of Plg. Indeed, these residues reside
on the outer surface of the bacterium in the current model
of free-form Lpp (Cowles et al., 2011). High sequence identity
was observed between Lpp and lipoproteins from various gram-
negative pathogens, including this C-terminal lysine residue
(Figure 1).
Recombinant Lpp was produced minus the 21 N-terminal
residues to facilitate recombinant protein production (henceforth
referred to as rLpp—see Table 1). rLpp was examined for the
ability to bind human Plg in vitro (Figure 2A). rLpp bound Plg
in a dose-dependent manner, and the aﬃnity of rLpp for Plg
was relatively strong, with a calculated dissociation constant (KD)
of 77 ± 16 nM, which is similar to other Plg binding proteins
that we have investigated (Floden et al., 2011). Additionally, we
examined the ability of rLpp to interact with plasmin (Figure 2B).
rLpp bound plasmin, suggesting that converted Plg can still be
2http://vassarstats.net/anova1u.html
TABLE 2 | A list of recombinant peptides generated in this study and their affinities for human plasminogen (Plg).
Peptide name Sequence Change in binding vs. normal
rLpp SSNAKIDQLSSDVQTLNAKVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK N/A
rLpp10C SSNAKIDQLSSDVQTLNAKVDQLSNDVNAMRSDVQAAKDDAARANQR None
rLpp30C SSNAKIDQLSSDVQTLNAKVDQLSNDV None
rLpp10N SDVQTLNAKVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK None
rLpp20N DQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK Decrease
rLpp30N RSDVQAAKDDAARANQRLDNAATKYRK Decrease
rLppK19A SSNAKIDQLSSDVQTLNAAVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK Increase
rLppQ14A N17A SSNAKIDQLSSDVATLAAKVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK Increase
rLppL16R A18K SSNAKIDQLSSDVQTRNKKVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK Decrease
rLppA18K SSNAKIDQLSSDVQTLNKKVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK None
rLppL16K SSNAKIDQLSSDVQTKNAKVDQLSNDVNAMRSDVQAAKDDAARANQRLDNAATKYRK None
Bolded text indicates putative Plg-binding domain.
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bound by Lpp in situ. These results, coupled with the high level
of sequence similarity between the Lpp of E. coli and other
Gram-negative bacteria demonstrate a potential role for Lpp and
homologs in E. coli and other bacteria in interactions with the
hosts’ ﬁbrinolytic system.
Lpp–Plg Interactions are Inhibited at High Ionic
Concentrations
We next tested the eﬀect of various inhibitors on rLpp–
Plg interactions. The ionic compound NaF was used to test
the importance of ionic residues in binding reactions (Jensen
et al., 2011). In principle, this reagent should interfere with
ionic interactions by competitively binding acidic or basic
residues. At 150 mM excess NaF, Lpp–Plg binding was inhibited
by a statistically signiﬁcant degree (Figure 2C). This result
suggests that ionic interactions may be important in Lpp–Plg
interactions. We then tested the ability of the lysine analog
aminocaproic acid (6-ACA) to interfere with Lpp–Plg binding.
No reduction in binding between Lpp and Plg occurs after
addition of relatively high levels of 6-ACA (Figure 2D). In
contrast, 6-ACA decreased binding of a control Plg-binding
protein from Borrelia burgdorferi (enolase; Figure 2D.). These
results suggest that ionic interactions play a role in Lpp–Plg
binding. However, contrary to our initial hypothesis, the data
obtained suggest that the C-terminal lysine of Lpp may not be
involved.
Truncations of the Lpp C-terminus do not
Affect Lpp–Plg Binding
According to the current model for free-form Lpp localization,
only the extreme C-terminus is available to the extracellular
environment of E. coli, and, therefore, is the most likely
site to facilitate interaction with ECM components like Plg.
Although a lysine analog did not aﬀect rLpp–Plg binding, ionic
residues may play a role (Figure 2C). We performed SDM
to produce an rLpp mutant with a non-sense mutation 10
residues upstream of the C-terminus (Table 2). We assayed
the ability of this mutant to bind Plg. Again, contrary
to our hypothesis, rLpp10C was able to bind Plg at an
aﬃnity equivalent to full-length rLpp, suggesting that the
actual Plg-binding domain of Lpp is located elsewhere in
the lipoprotein (Figure 3A). To verify that the Lpp mutants
could still interact with the anti-rLPP antibody, we performed
a Western blot against the truncated peptide. As shown in
Figure 3B, the truncated peptides demonstrated comparable
reactivity to antibodies generated against the full-length rLpp
(Figure 3B).
The Plg-binding Domain is Near the Center of
the Lpp Molecule
The discovery that Lpp–Plg binding occurs independent of
the extreme C-terminus prompted the generation of additional
Lpp truncations. Firstly, a 30-residue C-terminal truncation
was created, and was also found to bind Plg equivalent to
the parent rLpp (Figure 3A). To generate truncations of the
N-terminus while leaving the C-terminal domain intact, we
utilized overlap deletion PCR (Lee et al., 2010) to remove
FIGURE 3 | Lpp binds to Plg independently of the Lpp C-terminal
domain. ELISA was performed to analyze the binding between Plg and Lpp
C-terminal truncations (A), and a Western blot was performed to verify that
the mutants used retained receptivity to the αLpp antibodies generated during
this study (B). No statistically significant differences were observed between
Lpp and C-terminal truncation mutants’ binding to human Plg.
10, 20, and 30 residues from the N-terminus of rLpp. As
the rLpp is a small protein, between the N- and C-terminal
truncations generated, every potential binding region of the
protein was analyzed. We observed a distinct drop in aﬃnity
between the 10 and 20-residue truncations (Figure 4A). To verify
that the Lpp mutant interacted with the generated antibodies,
we performed a Western blot against the truncated peptides,
and noted no lack or increase of binding when compared
to full-length rLpp (Figure 4B). These data suggest that at
least part of the Plg-binding site of Lpp is located between
residues 10 and 20, and ends before V27, as C-terminal
truncations up to that reside did not negatively impact
binding.
As we were able to reduce binding earlier with ionic additives
(Figures 2C,D), we hypothesized that charged residues might
play a role in the interaction. To test this hypothesis we
performed SDM on several residues in the residue 10–20
domain. The mutation of three residues in particular—Q14,
N17, and K19—actually caused an increase in the aﬃnity of
Lpp for Plg (Figure 4C). With this new information taken
Frontiers in Microbiology | www.frontiersin.org 6 October 2015 | Volume 6 | Article 1095
Gonzalez et al. E. coli Lpp binds plasminogen
FIGURE 4 | Neutral residues near the N-terminus of Lpp are required
for optimal binding of Plg by Lpp. The N-terminal truncations of Lpp were
analyzed via ELISA for binding to human Plg (A), and their ability to be
recognized by our αLpp was confirmed by Western blot (B). ELISA was
performed to assess binding of Lpp by site-directed mutagenesis variants
lacking ionic (C) as well as non-polar amino acids (D).
FIGURE 5 | Plg bound by Lpp can be converted to active plasmin by
uPA. A Plg activation assay was performed using BSA (negative control), Lpp,
and borrelial enolase (positive control) as coating proteins and human
urokinase plasminogen activator (uPA) as the activator. ∗p < 0.05 when
compared to BSA negative control value.
FIGURE 6 | Antibodies against Lpp do not interfere Plg with binding to
whole cells. E. coli were treated with αLpp antibodies or pre-immunized
mouse serum (control). Binding was quantitated by bacteria/field of view (FOV)
by dark field microscopy. No difference was seen comparing the two groups
with regards to Plg binding.
into account, we decided to target the hydrophobic residues
in this region. We were able completely eliminate detectable
binding by mutating the L16 and A18 residues to either acidic
or basic amino acids. However, when the residues were mutated
individually, no phenotype was seen, suggesting a compensatory
role in Plg binding (Table 2). Altogether, the data suggest an
importance for hydrophobic residues in the interaction of Lpp
with Plg.
Plg Bound by Lpp can be Converted to Active
Plasmin
An interaction with a binding protein may result in a
conformational alteration of Plg (Fulde et al., 2013). This
conformational change allows Plg to be recognized and activated
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FIGURE 7 | The putative Plg-binding domain of rLpp is similar to that of another moonlighting protein. A Clustal W2 alignment of rLpp and a previously
described Plg-binding peptide from PDHB of Mycoplasma pneumoniae.
to plasmin by host factors tPA and uPA (Lähteenmäki et al., 2005;
Lin and Hu, 2014), resulting in a functional protease. To test
whether Lpp-bound Plg could be converted to active plasmin,
a chromogenic assay (Floden et al., 2011) was employed in the
presence of Lpp-bound Plg and uPA. Our results indicate that,
when bound by Lpp, Plg could be converted to active plasmin
(Figure 5). Altogether, these data suggest that an alternative role
for Lpp may be as a functional Plg receptor on the surface of
E. coli.
Anti-Lpp Antibodies do not Interfere with
Whole E. coli Binding to Immobilized Plg
To examine the functionality of Lpp–Plg interactions in
intact E. coli, we performed a binding assay using dark ﬁeld
microscopy. No diﬀerence was seen with E. coli binding to
immobilized Plg on glass slides even after treatment with αLpp
antibodies up to a dilution of 1:50 in the bacterial suspension
(Figure 6).
Discussion
A location for the free form of E. coli Lpp was recently
proposed (Cowles et al., 2011), and although a deﬁnitive
function for this protein form has not been delineated, several
potential roles have been postulated. Whatever the true function
of free-form Lpp, it is likely to be conserved between at
least several species of Enterobacteriaceae due to the highly
conserved nature of the protein (Figure 1). Lpp has a critical
role in infection likely because bacterial mutants lacking in
all forms of Lpp are severely structurally compromised even
under ideal culture conditions (Sha et al., 2004). By studying
the speciﬁc domains of the protein, we may be better able
to speciﬁcally understand the importance of free-form Lpp in
bacterial pathogenesis.
In our investigation of the protein–protein interactions, we
were surprised by the nature of the described binding activity.
Most proteins that interact with Plg are highly aﬀected by the
addition of ionic inhibitors such as sodium salts and heparin,
as the interactions are mostly mediated through charged amino
acids (Walker et al., 2005; Fulde et al., 2013). However, ionic
compounds were required in relatively high concentrations to
have the anticipated eﬀect (Figure 2C). Moreover, many proteins
that can bind Plg depend on C-terminal lysine residues to
facilitate the interaction with Plg (Miles et al., 1991; Brissette
et al., 2009; Floden et al., 2011; Bhattacharya et al., 2012;
Önder et al., 2012). Removing up to 30 residues from the
C-terminus of Lpp had no eﬀect on the protein’s ability to bind
Plg (Figure 3). Studies have shown that other bacterial proteins
have non-terminal Plg binding domains that may use other
amino acid motifs, most notably positively charged residues in a
hydrophobic pocket (Walker et al., 2005; Sanderson-Smith et al.,
2007). Lpp naturally forms multimers in intact bacteria (Shu
et al., 2000) which are clearly visible in Figure 3B. The possibility
remains that in our puriﬁcation of rLpp and the various mutants
from E. coli that wild-type Lpp was also puriﬁed, thereby
confounding our results. However, the mobility of full-length Lpp
and the truncation mutants (Figure 3B) argues against signiﬁcant
wild-type LPP contamination in our protein preparation. The
results of our assay utilizing 6-ACA (Figure 2D) bolster our
conﬁdence in the conclusion that the extreme carboxyl terminus
of Lpp (i.e., the C-terminal lysines) is not involved in Lpp–Plg
interactions. Future investigations may be necessary to verify
these ﬁndings.
By scanning from the N-terminus of our rLpp with 10-residue
truncations, we found a domain that we hypothesized could
be involved in Plg binding. Mutation of the asparagine and
lysine residues in this pocket, however, yielded a protein that
had a higher aﬃnity for Plg, while mutation of the hydrophobic
residues resulted in an Lpp mutant completely unable to interact
with this host zymogen (Figures 4C,D). To reconcile these data
with those obtained earlier (Figures 2C,D), we hypothesize that
the addition of ionic compounds to the binding buﬀer may
interfere with interactions by disrupting the tertiary structure
of either Lpp or Plg at the pertinent domain. Additionally, our
mutation of charged residues in the examined domain may
negatively aﬀect the structure of the binding site by altering
the charge of the overall binding region. As discussed above,
a hydrophobic pocket is required for this alternative binding
strategy of atypical Plg-binding proteins (Walker et al., 2005;
Sanderson-Smith et al., 2007).
Of note, the putative location of the Plg binding in rLpp is
localized in this study to the domain 16LNAKVDQLSNDV27
the N-terminus of this peptide was determined by the SDM
in Figure 4, and the C-terminus was the last amino acid
not aﬀected by the large truncations in Figure 3 (bolded
on the Lpp sequence in Table 2). This sequence is similar
to a previously identiﬁed Plg-binding domain identiﬁed on
the pyruvate dehydrogenase subunit B from Mycoplasma
pneumoniae: 91FPAMFQIFTHAA102 (Thomas et al., 2013). In
fact an alignment of the M. pneumoniae peptide with full-
length rLpp yields an overlap at exactly that domain (Figure 7).
While only one residue was identical between the two sequences,
most other residues were annotated as conserved in function.
This result is particularly interesting, as PDHB is another
“moonlighting” protein found in both the inner and extracellular
compartments of the bacterium (Henderson and Martin, 2011).
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Under the model for free-form Lpp localization that has
been recently described, the proposed Plg-binding domain would
be unavailable for interactions with host molecules, as only
the extreme C-terminus of the protein is proposed to be
exposed (Bernstein, 2011; Cowles et al., 2011) when free-form
Lpp is bound to bacterial outer membrane. The model for
subcellular localization of Lpp was based on the biotin labeling
of outer-membrane proteins in E. coli. With the deletion of
the Lpp C-terminus, the authors saw a complete elimination
in the biotinylation of the protein. However, examination of
the structure of Lpp reveals an extremely well-organized α-helix
structure with a disorganized C-terminal end (Shu et al., 2000).
The biotinylation reagent used in this study may only have been
able to eﬀectively label those disorganized ends, which would
explain the speciﬁcity of labeling without the necessity that the
remainder of the protein be sequestered within the bacterial outer
membrane. In that study, the authors also addressed the issue that
trimeric Lpp would not be able to insert into a membrane (Shu
et al., 2000; Cowles et al., 2011). Further studies will be needed
to elucidate the exact positioning of Lpp in the outer membrane,
though the evidence to date strongly supports the current model.
Additionally, our experiments indicated no diﬀerence in Plg
binding for intact E. coli when cells were treated with αLpp
antibodies generated in our lab. This could be due to a number
of factors. Firstly, E. coli has additional proteins that facilitate Plg
binding (Parkkinen and Korhonen, 1989; Sjöbring et al., 1994).
The role for multiple, independent Plg binding proteins has yet
to be determined, but could allow for diverse functions of the
diﬀerent proteins, or simply allow for some proteins to be lost,
in a case of classic redundancy. In fact, our results indicate that
the other Plg-binding proteins may be able to bind this host
protein simultaneously with Lpp, as the normal inhibitor 6-ACA
had no eﬀect on Lpp–Plg interactions. Simultaneous binding
of a single host protein by multiple bacterial eﬀectors could
have a number of potential roles/functions, including potentially
allowing for a tighter binding in vivo than can be observed in
vitro.
Another explanation for the result presented in Figure 6 is that
Lpp is not exposed on the surface of intact E. coli; thereby further
supporting the current model of Lpp localization. If free-form
Lpp is, in fact, integrated into the membrane and not available
in intact bacteria, there still exists a possible role for the protein.
The outer membrane of some bacteria can be highly volatile,
with a rapid turnaround rate for molecules embedded therein
(Manning and Kuehn, 2013; Kulkarni and Jagannadham, 2014).
For example, it is well known that LPS can be found ﬂoating
freely in infected tissues. It is conceivable, then, that free-form
Lpp may be released from the membrane where it could act as
a Plg-binding protein. While this phenomenon would preclude
Lpp from recruiting the Plg to the bacterial cell surface in the
absence of another receptor, Lpp may still play a role in plasmin
activation in the environment surrounding the invading E. coli.
Indeed, Lpp binding still allows for activation of Plg to plasmin
by uPA (Figure 5) and may actively bind that converted plasmin
(Figure 2C). Outer membrane vesicles could clear a path for
E. coli and other Enterobacteriaceae by acting as decoys for host
immune responses and by facilitating dissemination via Lpp–Plg
degradation of extracellular matrix (Ellis and Kuehn, 2010).
Although we found that Lpp can bind Plg, many aspects of
the interaction still remain unknown. While we feel conﬁdent
that the interaction does not depend on the C-terminal residues,
elucidation of the structure from the newly created mutants may
help us further identify the residues important for interactions.
E. coli Lpp mutants already exist that are unable to produce
either the free or bound forms of Lpp (Zhang and Wu, 1992;
Cowles et al., 2011). With these new mutants we may be able
to further diﬀerentiate between the functions of the two Lpp
subtypes without having to completely eliminate either species
from the cell. In fact, a more targeted approach could employ the
mutants created during this study (Figure 4) to further identify
the role of the described Plg binding. Finally, we also hope to
further add to the knowledge of Lpp localization in the cell,
possibly via the use of monoclonal antibodies to speciﬁc Lpp
domains.
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